Document Detail


Applicability and Mid-Term Results of Endovascular Treatment for Descending Thoracic Acute Aortic Syndromes.
MedLine Citation:
PMID:  23988554     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Descending thoracic acute aortic syndromes (DTAASs) are life-threatening pathologies in which thoracic endovascular aortic repair (TEVAR) is an attractive therapeutic option. There are few data in the literature on the survival and morbidity rates of TEVAR in such indications. We provide the results of TEVAR from our single-center cohort of DTAASs: ruptured aneurysms (RAs), acute symptomatic dissections (ADs), and traumatic ruptures (TRs).
METHODS: Between 2004 and 2011, data from all patients treated by TEVAR for DTAAS in our university center were collected prospectively. Primary end points were rates of 30-day mortality and morbidity. Secondary end points were mid-term outcomes and reinterventions.
RESULTS: Forty-eight patients underwent TEVAR for DTAASs: 19 RAs (39.6%), 12 ADs (25.0%), and 17 TRs (35.4%). The cumulative 30-day mortality and morbidity rate was 33%. There were 10 deaths (6 RAs, 1 AD, and 3 TRs), 2 cases of paraplegia (0 postoperative and 2 preoperative cases (2 TRs), and no major reinterventions and 4 minor reinterventions (embolization for endoleak exclusion). Long-term outcomes were known in 33 patients (5 patients were lost to follow-up), with a mean duration follow-up of 27 months. The cumulative mortality and morbidity rate was 9%: no deaths were reported, and 2 major reinterventions (open aneurysm repair) and 1 minor reintervention (endoleak exclusion) were required.
CONCLUSIONS: Our results confirm that TEVAR, as an emergency therapeutic option, is suited to DTAASs. The 21% perioperative mortality rate for such dramatic lesions remains high but is lower than medical or open repair therapeutic options previously reported. No additional deaths occurred during the 2-year follow-up period, and a low incidence of endograft-related reinterventions was observed. Nevertheless, scheduled follow-up visits with computed tomodensitometry scans on a regular basis are mandatory.
Authors:
Jean-Marc Alsac; Tibault Pierard; Salma El Batti; Paul Achouh; Pierre Julia; Jean-Noël Fabiani
Related Documents :
24774284 - Comparison of drug-eluting and bare metal stents in saphenous vein grafts. immediate an...
14962414 - Photodynamic therapy for age-related macular degeneration in a clinical setting: visual...
18303234 - Meta-analysis of chromovitrectomy with indocyanine green in macular hole surgery.
24159254 - A randomized clinical trial comparing the effect of different haemostatic agents for ha...
10227924 - Postoperative total parenteral nutrition.
15813834 - Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-8-26
Journal Detail:
Title:  Annals of vascular surgery     Volume:  -     ISSN:  1615-5947     ISO Abbreviation:  Ann Vasc Surg     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-8-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703941     Medline TA:  Ann Vasc Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Elsevier Inc. All rights reserved.
Affiliation:
Hopital Européen Georges Pompidou, Faculté de Médecine René Descartes, Université Paris 5, Paris, France. Electronic address: Jean-marc.alsac@egp.aphp.fr.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Segmental Arterial Mediolysis: A Systematic Review of 85 Cases.
Next Document:  Pregnancy management among teenagers under 15 years old: A multidisciplinary challenge.